NCT06085287Completed
Electromagnetic Therapy for Autism Spectrum Disorder
Electromagnetic Therapy for Autism Spectrum Disorder: a Pilot Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 29 Apr 2026
Brief summary (registry, in English)
The investigators hypothesize that electromagnetic therapy (EMT) could produce greater improvement on Autism spectrum disorder (ASD) compared to the waitlist control. To test this hypothesis, a pilot randomized waitlist-controlled trial is designed to achieve the 2 aims: 1. To evaluate the efficacy of EMT in improving children with ASD as measured by Childhood Autism Rating Scale (CARS) by comparing the change in CARS scores from baseline to week 12 between the two groups. 2. To assess the safety of EMT by comparing the number of participants with adverse events, number of participants withdrawn and reasons of withdrawal in treatment group with those in the control group. A pilot randomized waitlist-controlled trial is designed. A total of 30 children aged 3-12 years with a principal diagnosis of ASD will be recruited. They will be randomly assigned to Care-As Usual (CAU) and CAU+EMT groups (n = 15 each group). Participants on the CAU+EMT group will receive a total of 30 sessions of EMT within 12 weeks (2 - 3 sessions/week).Those who are initially assigned to CAU group will receive EMT for 12 weeks after they complete the trial. The post-trial treatment will serve as a compensation for their participation.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 6 Jul 2023
- Start date
- 4 Mar 2024
- Primary completion date
- 5 Dec 2024
- Lead sponsor
- The University of Hong Kong
- Diseases
- Autism
- NCT number
- NCT06085287
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 4 Mar 2024 to the primary completion date, 5 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Children have participated in other investigational studies in previous 3 months;
- Children have pediatric massage or acupuncture in previous 2 months; or
Other illness
- Children suffer a significant comorbid congenital disease or brain injury, such as Down syndrome, mental retardation, and cerebral palsy;
- Children have been suffering uncontrolled epilepsy or seizure;
- Children have heart diseases;
Other
- they have severe skin lesions or scar on the areas the treatment will be performed.
Who the study is looking for
- aged 3-12 years;
- have had a principal diagnosis of ASD according to the diagnostic criteria for ASD in the DSM-5;
- The score of CARS is 30-37 (mild to moderate ASD) at entry; and
- his/her parents or legal guardian give a written informed consent that indicates the permission to participate in the study.
Age in the registry: 3 years to 12 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Clinical Services Centres, The School of Chinese Medicine, The University of Hong Kong Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.